(Q80067100)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Selective indole-based ECE inhibitors: synthesis and pharmacological evaluation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Michael Brands

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jens-Kerim Ergüden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kentaro Hashimoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dirk Heimbach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Thomas Krahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Christian Schröder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Stephan Siegel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Johannes-Peter Stasch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hideki Tsujishita

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Stefan Weigand

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Nagahiro H Yoshida

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

96-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Historical review: Endothelin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Neurohumoral Activation and Ventricular Arrhythmias in Patients with Decompensated Congestive Heart Failure:

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Increased plasma endothelin-1 in the early hours of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Endothelin receptor antagonists: clinical realities and future directions.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Atrasentan: targeting the endothelin axis in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Protective effect of an oral endothelin converting enzyme inhibitor on rat detrusor function after outlet obstruction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

https://api.crossref.org/works/10.1002%2FCMDC.200500009

1 reference

7 January 2021

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Molecular properties that influence the oral bioavailability of drug candidates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500009

7 January 2021

Identifiers

DOI

10.1002/CMDC.200500009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892341%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference